Senior insider sale
Chief Commercial Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$7.1K
11.13K shares
What this filing means
BALDRY MARK plans to sell 11.13K shares of X4 PHARMACEUTICALS, INC valued at approximately $7.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/7/2024ACC: 0001973141-24-000489
Officer· Chief Commercial Officer
Since Nov 2022
11.13K
Shares to sell
$7.1K
Approx. market value
11.13K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Award
N/A
10/4/2024
11.13KTotal acquired11.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/4/2024 | Stock Award N/A | 11.13K | — |
| Total | 11.13K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.13K
Market value
$7.1K
10/7/2024
Total
Units
11.13K
Value
$7.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/7/2024 | 11.13K | $7.1K | NASDAQ | Planned |
| Total | 11.13K | $7.1K | ||